Nic is a seasoned senior global and regional leader with a proven track record in developing innovative strategies and executing them effectively. With extensive experience in both large-scale and mid-sized pharmaceutical companies, as well as a background in market access and operational expertise spanning the EU, US, Japan, and China, Nic brings a wealth of knowledge to the table. 

Beyond his corporate roles, Nic has successfully established three consulting firms specializing in market access and early commercialization. His expertise lies in guiding pharmaceutical development from phase 2 onwards. His remarkable portfolio boasts the launch of 14 market-leading medicines across various therapeutic areas such as Cardiovascular, Haematology, Ophthalmology, CNS, CG&T, and Infectious Diseases. 

Moreover, Nic is deeply committed to nurturing talent, recognizing that the foundation of any successful enterprise lies in its people. In his previous position, his team was celebrated for its leadership in diversity, empowerment, and fostering an environment where individuals could thrive and excel professionally.